FDA Approves Zarxio, First Biosimliar Drug – New York Times | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« This is what happens to your brain when you stop eating sugar

Imaging the 3D structure of a single virus using the world’s most powerful x-ray free-electron laser »

FDA Approves Zarxio, First Biosimliar Drug – New York Times

March 9, 2015 by 2012pharmaceutical

The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market.

Source: www.nytimes.com

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Posted in Uncategorized | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,079 other subscribers

Email Address
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: